Last reviewed · How we verify
Precocious puberty
Approved treatments
- Lupron · Accord Healthcare S.L.U.
Leuprolide acetate, a long-acting GnRH analog, initially stimulates then suppresses pituitary gonadotropins, reducing gonadal steroid secretion. - Synarel · Pfizer
- Lupron · Accord Healthcare S.L.U.
Lupron works by binding to and activating the gonadotropin-releasing hormone receptor, which ultimately leads to a decrease in the production of sex hormones. - Vantas
Vantas works by binding to the gonadotropin-releasing hormone receptor, mimicking the natural hormone and reducing the production of sex hormones. - Leuprolide Acetate · Pfizer
Leuprolide acetate is a manufactured version of a hormone that regulates growth and development, used to treat hormone-related conditions. - Eligard · Astellas Pharma Europe Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Precocious puberty patent landscape — cliff calendar, originator estates, attackable patents
- Precocious puberty treatment landscape brief
- Precocious puberty treatment updates RSS
Frequently asked questions about Precocious puberty
What drugs treat Precocious puberty?
Tracked treatments include Lupron, Synarel, Vantas, Leuprolide Acetate, Eligard.
What is the treatment for Precocious puberty?
Standard treatment for Precocious puberty includes Lupron, Synarel, Vantas, Leuprolide Acetate, Eligard. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Precocious puberty patent cliff · Precocious puberty CI report
- Treatment: Lupron · Accord Healthcare S.L.U.
- Treatment: Synarel · Pfizer
- Treatment: Lupron · Accord Healthcare S.L.U.
- Treatment: Vantas
- Treatment: Leuprolide Acetate · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing